Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Elisabeth, Baudin"'
Autor:
Estelle Pasquier, Onikepe O. Owolabi, Tamara Fetters, Richard Norbert Ngbale, Mariette Claudia Adame Gbanzi, Timothy Williams, Huiwu Chen, Claire Fotheringham, Daphne Lagrou, Catrin Schulte-Hillen, Bill Powell, Elisabeth Baudin, Veronique Filippi, Lenka Benova
Publikováno v:
BMC Pregnancy and Childbirth, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Abortion-related complications are one of the five main causes of maternal mortality. However, research about abortion is very limited in fragile and conflict-affected settings. Our study aims to describe the magnitude and severit
Externí odkaz:
https://doaj.org/article/9e0dd03474ae4b7bb9eb208da91d5744
Autor:
Michael T. Bretscher, Prabin Dahal, Jamie Griffin, Kasia Stepniewska, Quique Bassat, Elisabeth Baudin, Umberto D’Alessandro, Abdoulaye A. Djimde, Grant Dorsey, Emmanuelle Espié, Bakary Fofana, Raquel González, Elizabeth Juma, Corine Karema, Estrella Lasry, Bertrand Lell, Nines Lima, Clara Menéndez, Ghyslain Mombo-Ngoma, Clarissa Moreira, Frederic Nikiema, Jean B. Ouédraogo, Sarah G. Staedke, Halidou Tinto, Innocent Valea, Adoke Yeka, Azra C. Ghani, Philippe J. Guerin, Lucy C. Okell
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-17 (2020)
Abstract Background The majority of Plasmodium falciparum malaria cases in Africa are treated with the artemisinin combination therapies artemether-lumefantrine (AL) and artesunate-amodiaquine (AS-AQ), with amodiaquine being also widely used as part
Externí odkaz:
https://doaj.org/article/d63fb89dbad4435d99d8cdb398f06c3b
Autor:
Ann M. Moore, Estelle Pasquier, Timothy Williams, Tamara Fetters, Bill Powell, Mariette Claudia Adame Gabanzi, Nadine Neema Mitutso, Lucien Ngabo Muamira, Onikepe Owolabi, Claire Fotheringham, Huiwu Chen, Daphne Lagrou, Elisabeth Baudin, Catrin Schulte-Hillen, Richard Ngbale
Background Conducting abortion research in fragile settings presents challenges, many of which are present in other low-resourced settings to various degrees but when appearing all together, collectively served to create a set of barriers to collecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f5e9794c9b769ae9a377b3a225dc925
https://doi.org/10.21203/rs.3.rs-2671712/v1
https://doi.org/10.21203/rs.3.rs-2671712/v1
Autor:
Ann Moore, Estelle Pasquier, Timothy Williams, Tamara Fetters, Bill Powell, Mariette Claudia Adame Gbanzi, Nadine Neema Mitutso, Lucien Ngabo Mulamira, Onikepe Owolabi, Claire Fotheringham, Huiwu Chen, Daphne Lagrou, Elisabeth Baudin, Catrin Schulte-Hillen, Richard Ngbale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c199e8e75dc9392e3c8bb2905b35a7c
https://doi.org/10.22541/au.165659048.82096672/v1
https://doi.org/10.22541/au.165659048.82096672/v1
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug–drug interaction randomized trial
Autor:
Daniel, Atwine, Elisabeth, Baudin, Thibaut, Gelé, Winnie, Muyindike, Kenneth, Mworozi, Racheal, Kyohairwe, Keneth, Kananura, Patrick, Orikiriza, Dan, Nyehangane, Deborah, K T Nanjebe, Valérie, Furlan, Céline, Verstuyft, Aurélie, Barrail-Tran, Anne-Marie, Taburet, Maryline, Bonnet, P, Justumus
Publikováno v:
Journal of Antimicrobial Chemotherapy. 75:1250-1258
We regret that this article is behind a paywall.
Background: High-dose rifampicin is considered to shorten anti-TB treatment duration but its effect on antiretroviral metabolism is unknown. Objectives: To assess the effect of doubling the rifamp
Background: High-dose rifampicin is considered to shorten anti-TB treatment duration but its effect on antiretroviral metabolism is unknown. Objectives: To assess the effect of doubling the rifamp
Autor:
B. C. de Jong, S. B. Patil, M. Atger, N. Saluhuddin, Gabriella Ferlazzo, Vivian Cox, Helen McIlleron, Lawrence Oyewusi, Elmira A. Berikova, Aamir J. Khan, S. Wasserman, Michael Rich, M. Moschioni, D. Dos Santos Tozzi, Julia Coit, C. Delifer, L. Pichon, V. Ducher, Lorenzo Trippa, M. Gouillou, Lorenzo Guglielmetti, S. Panda, K. O’Brien, Matteo Cellamare, S. Cloez, Peter Zimetbaum, Carole D. Mitnick, Leonid Lecca, P. Rupasinghe, M. Mazmanian, Elisabeth Baudin, Uzma Khan, O. Okunbor, Maryline Bonnet, E. Chang, A. N. LaHood, Patrick P. J. Phillips, Gustavo E. Velásquez, Elisa Ardizzoni, M. Tamirat, Kwonjune J. Seung, N Lachenal, J. M. Do, Francis Varaine
Publikováno v:
Trials, vol 22, iss 1
Trials
Trials, BioMed Central, 2021, 22 (1), pp.651. ⟨10.1186/s13063-021-05491-3⟩
Trials, Vol 22, Iss 1, Pp 1-15 (2021)
Trials, 2021, 22 (1), pp.651. ⟨10.1186/s13063-021-05491-3⟩
Trials
Trials, BioMed Central, 2021, 22 (1), pp.651. ⟨10.1186/s13063-021-05491-3⟩
Trials, Vol 22, Iss 1, Pp 1-15 (2021)
Trials, 2021, 22 (1), pp.651. ⟨10.1186/s13063-021-05491-3⟩
Background Treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR-TB) is expensive, labour-intensive, and associated with substantial adverse events and poor outcomes. While most MDR/RR-TB patients do not receive treatment, many who do a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::476e2049884ad266a73b1f9c63d6be18
https://escholarship.org/uc/item/7fb6h2xd
https://escholarship.org/uc/item/7fb6h2xd
Autor:
Maryline Bonnet, Elisabeth Baudin, Ilesh V. Jani, Elizabete Nunes, François Verhoustraten, Alexandra Calmy, Rui Bastos, Nilesh B. Bhatt, Christophe Michon
Publikováno v:
PLoS ONE, Vol 9, Iss 1 (2014)
Externí odkaz:
https://doaj.org/article/06ed1c3315ab457295ebb217448516b3
Autor:
Maryline Bonnet, Elisabeth Baudin, Ilesh V Jani, Elizabete Nunes, François Verhoustraten, Alexandra Calmy, Rui Bastos, Nilesh B Bhatt, Christophe Michon
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84585 (2013)
We used data from a randomized trial of HIV-tuberculosis co-infected patients in Mozambique to determine the incidence and predictors of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (IRIS) occurring within 12 weeks
Externí odkaz:
https://doaj.org/article/2061b961a624450db0c9775eafb5e346
Autor:
Elizabeth Juma, Azra C. Ghani, Raquel González, Michael T. Bretscher, Sarah G. Staedke, Philippe J Guerin, Bertrand Lell, Umberto D'Alessandro, Elisabeth Baudin, Kasia Stepniewska, Emmanuelle Espie, Innocent Valea, Clarissa Moreira, Halidou Tinto, Clara Menéndez, Estrella Lasry, Abdoulaye Djimde, Nines Lima, Jamie T. Griffin, Jean-Bosco Ouédraogo, Lucy C Okell, Grant Dorsey, Ghyslain Mombo-Ngoma, Frederic Nikiema, Adoke Yeka, Quique Bassat, Corine Karema, Prabin Dahal, Bakary Fofana
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-17 (2020)
BMC Med
BMC Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Med
BMC Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
Background The majority of Plasmodium falciparum malaria cases in Africa are treated with the artemisinin combination therapies artemether-lumefantrine (AL) and artesunate-amodiaquine (AS-AQ), with amodiaquine being also widely used as part of season
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6b428836411d235e5beb84c0efc8eb8
http://hdl.handle.net/10044/1/76878
http://hdl.handle.net/10044/1/76878
Autor:
Clarissa Moreira, Jean-Bosco Ouédraogo, Ghyslain Mombo-Ngoma, Elisabeth Baudin, Elizabeth Juma, Abdoulaye Djimde, Emmanuelle Espie, Bakary Fofana, Frederic Nikiema, Nines Lima, Jamie T. Griffin, Michael T. Bretscher, Grant Dorsey, Clara Menéndez, Corine Karema, Estrella Lasry, Philippe J Guerin, Adoke Yeka, Bertrand Lell, Prabin Dahal, Kasia Stepniewska, Lucy C Okell, Umberto D'Alessandro, Azra C. Ghani, Quique Bassat, Raquel González, Sarah G. Staedke, Halidou Tinto, Innocent Valea
Artemether-lumefantrine (AL) and artesunate-amodiaquine (AS-AQ) are the most commonly-used treatments against Plasmodium falciparum malaria in Africa. The lumefantrine and amodiaquine partner drugs may provide differing durations of post-treatment pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63cc37616ae111ea2267b8891b0c40b8
https://doi.org/10.1101/19002741
https://doi.org/10.1101/19002741